Article Information
History
- July 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ryan S. Dhindsa1,2,3,*,
- Quanli Wang3,
- Dimitrios Vitsios4,
- Oliver S. Burren4,
- Fengyuan Hu4,
- James E. DiCarlo5,
- Leonid Kruglyak6,7,
- Daniel G. MacArthur8,9,10,
- Matthew E. Hurles11 and
- Slavé Petrovski4,12,*
- 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
- 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
- 3Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA
- 4Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 5Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- 6Department of Human Genetics and Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, CA, USA
- 7Howard Hughes Medical Institute, Chevy Chase, MD, USA
- 8Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 9Centre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, NSW, Australia
- 10Centre for Population Genomics, Murdoch Children’s Research Institute, Melbourne, VIC, Australia
- 11Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
- 12Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia
- ↵*Correspondence:
ryan.dhindsa{at}bcm.edu (R.S.D.), slav.petrovski{at}astrazeneca.com (S.P)